DEVELOPMENT OF MESALAZINE MICROSPHERES FOR COLON TARGETING


Katta Rajesh, R. Deveswaran, S. Bharath, B. V. Basavaraj

Abstract


Objective: The present work was aimed at preparation of mesalazine microspheres by a non-aqueous solvent evaporation method using eudragit S 100 and eudragit L 100 as pH dependent polymers for colon targeting.

Methods: The ratio of drug to polymer was varied and the effect of formulation variables revolutions per minute (RPM) (1000, 1500, 2000 and 2500) and concentration of span 80 (1%, 1.5%, 2% and 2.5%) were studied. Prepared microspheres were evaluated for particle size, percent drug entrapment, granular analysis, in vitro drug release studies, Fourier transformed infrared spectroscopy (FT-IR) Differential Scanning Calorimetry (DSC), X-ray diffraction (XRD) and scanning electron microscopy (SEM) studies.

Results: Particle size has decreased and percent drug entrapment had increased with increase in RPM in all formulations. When the span 80 concentration increased, the particle size of the microsphere formulations increased and percent drug entrapment decreased in eudragit S 100 microspheres; whereas in eudragit L 100 microspheres, as the concentration of span 80 increased, the particle size of the microsphere formulations decreased. The prepared microspheres sustained the drug release over a period of 12 h.

Conclusion: Thus eudragit S 100 and eudragit L 100 microspheres could constitute a promising approach for colon-specific and sustained delivery of mesalazine for the treatment of inflammatory bowel disease.


Keywords


Microspheres, Mesalazine, Eudragit S 100, Solvent evaporation, Inflammatory bowel disease

| PDF | HTML |

References


Kumar KPS, Bhowmik D, Srivastava S, Paswan S, Dutta AS. Sustained release drug delivery system potential. Pharm Innovat 2012;1:48-60.

Dehghan S, Aboofazeli R, Avadi M, Khaksar R. Formulation optimization of nifedipine-containing microspheres using factorial design. Afr J Pharm Pharmacol 2010;4:346-54.

Patel JK, Patel RP, Amin AF, Patel MM. Formulation and evaluation of mucoadhesive glipizide microspheres. AAPS PharmSciTech 2005;6:E49-E55.

Huyghebaert N, Vermeire A, Remon JP. In vitro evaluation of coating polymers for enteric coating and human ileal targeting. Int J Pharm 2005;298:26-37.

Gupta VK, Beckert E, Price JC. A novel pH-and time based multiunit potential colonic drug delivery system. Int J Pharm 2001;213:93-102.

Deveswaran R, Manavalan R, Madhavan V, Bharath S. Development and evaluation of aceclofenac loaded ethyl cellulose microspheres. Asian J Pharm Sci 2012;7:50-7.

Hanauer SB. Aminosalicylates in inflammatory bowel disease. Aliment Pharmacol Ther 2004;20:60–5.

Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417–29.

Mahida YR, Lamming CE, Gallagher A, Hawthorne AB, Hawkey CJ. 5-aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease. Gut 1991;32:50–4.

Cominelli F, Nast CC, Duchini A, Lee M. Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology 1992;103:65–71.

Swapna A, Mohd AB, Wamorkar V, Swathimutyam P. Formulation and evaluation of mesalamine microspheres for colon targeted drug delivery system. J Pharm Res 2011;4:1670-2.

Najmuddin M, Sachin S, Asgar Ali, Patel V, Khan T. Formulation and in vitro evaluation of floating microspheres of ketoprofen prepared by emulsion solvent diffusion method. Int J Appl Pharm 2010;2:13-7.

Aulton ME. Pharmaceutics: The science of dosage form design. 9th Edition. London: Churchill Livingstone; 1999. p. 610.

Tong Dang, Ying Cui, Yan-Dong Chen, Xian-Mei Meng, Bo-Fu Tang, Jin-BaoWu. Preparation and characterization of colon-specific microspheres of diclofenac for colorectal cancer. Trop J Pharm Res 2015;14:1541-7.

Grimm W. Extension of the international conference on harmonization tripartite guideline for stability testing of new drug substances and products to countries of climatic zones III and IV. Drug Dev Ind Pharm 1998;24:31325.

Sandeep K, Arun N. Formulation, optimization and in vitro evaluation of gastroretentive mucoadhesive microspheres of furosemide. Int J Pharm Pharm Sci 2016;8:392-8.

Khaled Al-Tahami. Preparation, characterization, and in vitro release of ketoprofen loaded alginate microspheres. Int J Appl Pharm 2014;6:9-12.




About this article

Title

DEVELOPMENT OF MESALAZINE MICROSPHERES FOR COLON TARGETING

Keywords

Microspheres, Mesalazine, Eudragit S 100, Solvent evaporation, Inflammatory bowel disease

DOI

10.22159/ijap.2017v9i4.17326

Date

13-07-2017

Additional Links

Manuscript Submission

Journal

International Journal of Applied Pharmaceutics
Vol 9, Issue 4, 2017 Page: 1-9

Online ISSN

0975-7058

Statistics

208 Views | 20 Downloads

Authors & Affiliations

Katta Rajesh
Department of Pharmaceutics, Faculty of Pharmacy, M.S.Ramaiah University of Applied Sciences, Bangalore 560054

R. Deveswaran
Department of Pharmaceutics, Faculty of Pharmacy, M.S.Ramaiah University of Applied Sciences, Bangalore 560054

S. Bharath
Department of Pharmaceutics, Faculty of Pharmacy, M.S.Ramaiah University of Applied Sciences, Bangalore 560054

B. V. Basavaraj
Department of Pharmaceutics, Faculty of Pharmacy, M.S.Ramaiah University of Applied Sciences, Bangalore 560054


Refbacks

  • There are currently no refbacks.